Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Pop Mart HK$5.2 billion IPO and Hong Kong listing
Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the…
Dexin China Holdings $200 million high-yield notes offering and tender offer
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Dexin China Holdings Company Limited…
Ingram Micro $7.2 billion acquisition by Platinum Equity
Davis Polk is advising Ingram Micro Inc. on its $7.2 billion acquisition by Platinum Equity from HNA Technology Co., Ltd, a…
Fujian Yango $75 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $75 million principal amount…
Fantasia Holdings $120 million high-yield notes reopening
Davis Polk advised the initial purchasers in connection with a Regulation S offering of $120 million 9.875% senior…
Ronshine China Holdings $150 million high-yield notes offering
Davis Polk advised the initial purchaser on the Regulation S offering of high-yield notes by Ronshine China Holdings Limited…
Shui On Land $200 million high-yield notes reopening
Davis Polk advised the sole lead manager in connection with a $200 million Regulation S green bonds offering of 5.75% senior…
China Distance Education going-private transaction
Davis Polk is advising the buyer group consisting of Mr. Zhengdong Zhu, co-founder, chairman of the board of directors and…
Antengene HK$2.79 billion IPO
Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong…
China Biologic going-private transaction
Davis Polk is advising the special committee of the board of directors of China Biologic Products Holdings, Inc. (“China…